✦ LIBER ✦

Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma

✍ Scribed by O W Tawfik; B F Kimler; M Davis; J K Donahue; D L Persons; F Fan; S Hagemeister; P Thomas; C Connor; W Jewell; C J Fabian

Book ID: 108780053
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 446 KB
Volume: 48
Category: Article
ISSN: 0309-0167
DOI: 10.1111/j.1365-2559.2005.02322.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of HER-2 status determined by

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

✍ Yun Gong; Daniel J. Booser; Nour Sneige 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Accurate assessment of __HER‐2__ status is necessary prior to anti‐__HER‐2__ antibody (trastuzumab) therapy for metastatic breast carcinoma. However, controversy exists regarding whether to assess __HER‐2__ status in the primary tumor or in metastatic lesions. It is also

Expression of HER-2/neu gene and protein

Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry

✍ G P Dagrada; T Negri; E Tamborini; M A Pierotti; S Pilotti 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

A comparison of five immunohistochemical

A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma

✍ Doo Ho Choi; Dong Bok Shin; Min Hyuk Lee; Dong Wha Lee; Devika Dhandapani; Darry 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this article was to compare five tumor markers between white women in the U.S. and native Korean women with early‐onset breast carcinoma. ## METHODS Sixty Korean women who were diagnosed with breast carcinoma at age 45 years or younger and 60 white wome